Karen Canfell

Journal article

Capacity of the 45 and Up Study to mobilise evidence-based improvements in cancer control: lung cancer case study

Over the 15 years since the 45 and Up Study was established, researchers have harnessed its capacity for enabling rigorous, comprehensive investigation of cancer causes, care, and outcomes. This paper uses lung cancer as a case study to demonstrate the Study’s potential to improve cancer...
Journal article

How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia

This article focuses on observed short-term impacts, adaptations and the longer-term outlook for cancer screening in relation to COVID-19. It summarises potential responses to minimise the harms of disruptions caused by COVID-19, and highlights research and policy opportunities in the pandemic response and recovery which...
Journal article

Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates

This study reviewed and, where possible, updated the estimated health benefits, harms and cost-effectiveness of screening approaches from modelling studies for four cancer types, PSA testing and Lynch syndrome testing in Australia. Costs are presented in 2018 Australian dollars.
Journal article

Impact of the Australian national cervical screening program in women of different ages

Starting cervical cancer screening at age 25 is safe. The findings support the Australian government’s renewed cervical screening program (set to come into effect in May 2017), which recommends that women should start screening for cervical cancer at age 25, not age 18-20. Abstract: The...